CoChat
Sign Up
Cited by 165Stress Responses and CortisolSleep and Wakefulness ResearchTreatment of Major Depression

The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.

Changes of Sleep Architecture, Spectral Composition of Sleep EEG, the Nocturnal Secretion of Cortisol, ACTH, GH, Prolactin, Melatonin, Ghrelin, and Leptin, and the DEX-CRH Test in Depressed Patients during Treatment with Mirtazapine

Schmid, Dagmar A, Wichniak, Adam, Uhr, Manfred, Ising, Marcus, Brunner, Hans, Held, Katja, Weikel, Jutta C, Sonntag, Annette, Steiger, Axel·2006·Neuropsychopharmacology
DOI 10.1038/sj.npp.1300923
Open this paper in CoChat — free account

Abstract

The noradrenergic and specific serotoninergic antidepressant mirtazapine improves sleep, modulates hormone secretion including blunting of hypothalamic-pituitary-adrenocortical (HPA) activity, and may prompt increased appetite and weight gain. The simultaneous investigation of sleep electroencephalogram (EEG) and hormone secretion during antidepressive treatment helps to further elucidate these effects. We examined sleep EEG (for later conventional and quantitative analyses) and the nocturnal concentrations of cortisol, adrenocorticotropin (ACTH), growth hormone (GH), prolactin, melatonin and the key factors of energy balance, ghrelin, and leptin before and after 28 days of treatment of depressed patients (seven women, three men, mean age 39.9+/-4.2 years) with mirtazapine. In addition, a sleep EEG was recorded at day 2 and the dexamethasone-corticotropin-releasing hormone (DEX-CRH) test was performed to assess HPA activity at days -3 and 26. Psychometry and mirtazapine plasma concentrations were measured weekly. Already at day 2, sleep continuity was improved. This effect persisted at day 28, when slow-wave sleep, low-delta, theta and alpha activity, leptin and (0300-0700) melatonin increased, and cortisol and ghrelin decreased. ACTH and prolactin remained unchanged. The first two specimens of GH collected after the start of quantitative EEG analysis were reduced at day 28. The DEX-CRH test showed, at day 26, a blunting of the overshoot of ACTH and cortisol found at day -3.…

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300923

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 90 references

2 of the 90 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Spitzer RL, Williams JB, Gibbon M (1987). The structured clinical interview for DSM-III-R: SCID. German version: Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour W. SKID—Strukturiertes Klinisches Inverview für DSM-III-R. Beltz: Weinheim.

Cited by

Sorted by citations

Items 101–165 of 165

Related

See all

Metadata

Authors
Schmid, D. A., Wichniak, A., Uhr, M., Ising, M., Brunner, H., Held, K., Weikel, J. C., Sonntag, A., & Steiger, A.
Affiliations
  • Max Planck Institute of Psychiatry (DE)
  • Max Planck Society (DE)
Corresponding author
Steiger, Axel
ORCID
Venue
Neuropsychopharmacology
Publisher
Springer Science and Business Media LLC
Published
2005-10-19
Volume
31
Issue
4
Pages
832-844
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
DOI
10.1038/sj.npp.1300923
OpenAlex
W1985871443
Cited by
165
References
90
Citations by year
2026: 8 · 2025: 8 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 2 · 2015: 9 · 2014: 13 · 2013: 9 · 2012: 14
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
mirtazapine, depression, sleep architecture, sleep EEG, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, growth hormone, prolactin, melatonin, ghrelin, leptin, 5-HT2 receptor, antidepressant side effects
MeSH terms
Mirtazapine, Adrenocorticotropic Hormone, Adult, Animals, Antidepressive Agents, Tricyclic, Body Weight, Circadian Rhythm, Depression, Dexamethasone, Dose-Response Relationship, Drug, Electroencephalography, Endocrine System, Female, Hormones, Humans, Hydrocortisone, Male, Melatonin, Mianserin, Middle Aged, Prolactin, Psychometrics, Sleep, Growth Hormone, Time Factors, Immunoradiometric Assay, Area Under Curve, Leptin, Peptide Hormones, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review